These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16997845)

  • 21. Fosfomycin: use beyond urinary tract and gastrointestinal infections.
    Falagas ME; Giannopoulou KP; Kokolakis GN; Rafailidis PI
    Clin Infect Dis; 2008 Apr; 46(7):1069-77. PubMed ID: 18444827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The therapeutic challenge of Gram-negative sepsis: prolonging the lifespan of a scarce resource.
    Richards GA
    Clin Microbiol Infect; 2005 Nov; 11 Suppl 6():18-22. PubMed ID: 16209702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of systematic empiric treatment with imipenem on the bacterial ecology in a burns unit.
    Le Floch R; Arnould JF; Pilorget A
    Burns; 2005 Nov; 31(7):866-9. PubMed ID: 16039784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Appropriate outpatient treatment of acute bacterial exacerbations of chronic bronchitis.
    Martinez FJ; Anzueto A
    Am J Med; 2005 Jul; 118 Suppl 7A():39S-44S. PubMed ID: 15993676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review: dalbavancin--a novel lipoglycopeptide antimicrobial for gram positive pathogens.
    Das B; Sarkar C; Biswas R; Pandey S
    Pak J Pharm Sci; 2008 Jan; 21(1):78-87. PubMed ID: 18166524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial management of sepsis and septic shock.
    Sharma S; Kumar A
    Clin Chest Med; 2008 Dec; 29(4):677-87, ix. PubMed ID: 18954702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imipenem levels are not predictable in the critically ill patient.
    Belzberg H; Zhu J; Cornwell EE; Murray JA; Sava J; Salim A; Velmahos GC; Gill MA
    J Trauma; 2004 Jan; 56(1):111-7. PubMed ID: 14749576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New antibiotic agents for bloodstream infections.
    Vergidis PI; Falagas ME
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S60-5. PubMed ID: 18723329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishing the role of tigecycline in an era of antimicrobial resistance.
    Schafer JJ; Goff DA
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):557-67. PubMed ID: 18847395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common pathogens isolated in diabetic foot infection in Bir Hospital.
    Sharma VK; Khadka PB; Joshi A; Sharma R
    Kathmandu Univ Med J (KUMJ); 2006; 4(3):295-301. PubMed ID: 18603922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Imipenem resistance in Gram-negative rods and its consumption between 1999 and 2005].
    Gospodarek E; Gierlotka K; Deptuła A; Michalska A
    Med Dosw Mikrobiol; 2007; 59(3):231-40. PubMed ID: 18078118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The importance of de-escalating antimicrobial therapy in patients with ventilator-associated pneumonia.
    Niederman MS
    Semin Respir Crit Care Med; 2006 Feb; 27(1):45-50. PubMed ID: 16508881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis.
    Schmit X; Vincent JL
    Infection; 2008 Jun; 36(3):213-9. PubMed ID: 18463788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Aspects of calculated and controlled antibiotic therapy].
    Rodloff AC
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():953-5. PubMed ID: 9574306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imipenem versus targeted therapy in cancer patients.
    Aoun M; Crokaert F; Paesmans M; Autier P; Klastersky J
    Int J Antimicrob Agents; 1998 Nov; 10(4):263-70. PubMed ID: 9916899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nosocomial pneumonia: aetiology, diagnosis and treatment.
    Depuydt P; Myny D; Blot S
    Curr Opin Pulm Med; 2006 May; 12(3):192-7. PubMed ID: 16582674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of aminoglycosides in modern therapy.
    Beaucaire G
    J Chemother; 1995 Jun; 7 Suppl 2():111-23. PubMed ID: 8622100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing therapy for vancomycin-resistant enterococci (VRE).
    Linden PK
    Semin Respir Crit Care Med; 2007 Dec; 28(6):632-45. PubMed ID: 18095227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.